Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables.
Solomon SR, Aubrey MT, Zhang X, Piluso A, Freed BM, Brown S, Jackson KC, Morris LE, Holland HK, Solh MM, Bashey A. Solomon SR, et al. Among authors: morris le. Biol Blood Marrow Transplant. 2018 Apr;24(4):789-798. doi: 10.1016/j.bbmt.2018.01.013. Epub 2018 Jan 31. Biol Blood Marrow Transplant. 2018. PMID: 29355721 Free article. Clinical Trial.
Comparison of outcomes following transplantation with T-replete HLA-haploidentical donors using post-transplant cyclophosphamide to matched related and unrelated donors for patients with AML and MDS aged 60 years or older.
Bashey ZA, Zhang X, Brown S, Jackson K, Morris LE, Holland HK, Bashey A, Solomon SR, Solh M. Bashey ZA, et al. Among authors: morris le. Bone Marrow Transplant. 2018 Jun;53(6):756-763. doi: 10.1038/s41409-018-0126-4. Epub 2018 Mar 9. Bone Marrow Transplant. 2018. PMID: 29523888
High-Dose Bendamustine, Etoposide, Cytarabine, and Melphalan (BeEAM) Conditioning Before Autologous Transplantation for Patients With Multiple Myeloma.
Solomon SR, Brown S, Shegda N, Jackson KC, Zhang X, Bashey A, Holland HK, Morris LE, Solh M. Solomon SR, et al. Among authors: morris le. Transplant Cell Ther. 2022 Aug;28(8):486.e1-486.e7. doi: 10.1016/j.jtct.2022.05.022. Epub 2022 May 20. Transplant Cell Ther. 2022. PMID: 35598842 Free article. Clinical Trial.
Lineage-Specific Relapse Prediction After Haploidentical Transplantation With Post-Transplant Cyclophosphamide Based on Recipient HLA-B-Leader Genotype and HLA-C-Group KIR Ligand.
Solomon SR, Aubrey MT, Zhang X, Jackson KC, Roark CL, Freed BM, Morris LE, Holland HK, Solh MM, Bashey A. Solomon SR, et al. Among authors: morris le. Transplant Cell Ther. 2022 Sep;28(9):601.e1-601.e8. doi: 10.1016/j.jtct.2022.06.023. Epub 2022 Jul 3. Transplant Cell Ther. 2022. PMID: 35788088 Free article.
174 results